Details of the Drug

General Information of Drug (ID: DMZYTWR)

Drug Name

PDM-08

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C11H15Br2N3O3
Canonical SMILES: C1C(NC(=O)C1(C[N+]2=CC=CC=C2)N)C(=O)O.Br.[Br-]
InChI: 1S/C11H13N3O3.2BrH/c12-11(7-14-4-2-1-3-5-14)6-8(9(15)16)13-10(11)17;;/h1-5,8H,6-7,12H2,(H-,13,15,16,17);2*1H/t8-,11+;;/m1../s1
InChIKey: GIZKBHWITTWBAP-IEQXMABBSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01380249) PDM08 Clinical Trial in Advanced Solid Tumors. U.S. National Institutes of Health.